News Search Results
Jan 02, 2026, 14:09 ET Hong Kong Tech Exhibits Immense Potential at CES 2026 with 61 Tech Companies Ready for Global Markets
and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland
More news about: Hong Kong Tech
Jan 02, 2026, 02:33 ET Last day of trading in shares with pre-emptive rights in connection with rights issue
company with operations in Denmark (HQ), Singapore, Turkey, the United States, and China. We are committed to rethinking water filtration with biotechnology to solve global water challenges. By combining three disciplines from the world of natural sciences: biology, chemistry, and physics, we have created
More news about: Aquaporin A/S
Jan 02, 2026, 02:29 ET Last day of trading in shares with pre-emptive rights in connection with rights issue
company with operations in Denmark (HQ), Singapore, Turkey, the United States, and China. We are committed to rethinking water filtration with biotechnology to solve global water challenges. By combining three disciplines from the world of natural sciences: biology, chemistry, and physics, we have created
More news about: Aquaporin A/S
Jan 01, 2026, 09:00 ET Immortal Dragons Comments on Longevity Regulation and Investment Trends Following FT Podcast Appearance
improving human healthspan. The fund currently supports more than 15 portfolio companies operating across diverse areas of longevity science and biotechnology. In addition to its investment activities, Immortal Dragons promotes longevity education and advocacy through book translation and publishing, translation
More news about: Immortal Dragons
Dec 30, 2025, 08:51 ET ROSM Selected to Lead Groundbreaking Clinical Trial for Osteoarthritis: $1M Grant Powers Search for Disease-Reversing Therapy
Collaboration with Global Potential This initiative is a testament to the power of Maryland's life sciences community. It brings together the biotechnology expertise of Britecyte, the clinical research capabilities of Amarex, and the patient-care excellence of ROSM. Together, these three organizations
More news about: Regenerative Orthopedics & Sports Medicine
Dec 30, 2025, 08:38 ET TOMO YUME Group Subsidiary SPARKLING SCIENCES Achieves Dual U.S. INCI Certifications, Accelerating Global Expansion of Advanced Exosome Ingredients
derived from Sparkling Sciences' advanced biotechnology, which integrates clinical-grade purification with freeze-drying processes:Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983)A premium biotechnology ingredient designed for advanced scalp
More news about: Sparkling Sciences
Dec 30, 2025, 07:00 ET Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
is a seasoned biotechnology and pharmaceutical executive with extensive experience in bridging science, business, and funding. She has a proven track record of leading R&D, clinical development, and business operations across the pharmaceutical, diagnostics, and agri-biotechnology sectors. Her prior
More news about: Evogene
Dec 30, 2025, 04:00 ET Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO
productivity that improves human health."Global Capital Endorsement: AI‑driven Biotech Lands on HKEXAs a global pioneer AI‑driven biotechnology company, Insilico's Hong Kong listing, jointly sponsored by Morgan Stanley, CICC and GF Securities, attracted strong interest and active participation
More news about: Insilico Medicine
Dec 29, 2025, 10:01 ET Healthcare Cloud Computing Market to Reach $54.72 B by 2033 | CAGR 13% | According to DataM Intelligence Report
UserHospitals and health systemsAmbulatory care centersHealth insurance providersPharmaceutical and biotechnology companiesResearch institutions and digital health startupsRequest Customized Intelligence Aligned to Your Business Strategy:
More news about: DataM Intelligence 4 Market Research LLP
Dec 29, 2025, 08:31 ET MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference
CAMBRIDGE, Mass., Dec. 29, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will participate in and sponsor the 10th Annual MASH-TAG
More news about: MetaVia Inc.
Dec 29, 2025, 08:05 ET FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Dec 29, 2025, 06:40 ET Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence
size of US$10.94 billion in 2022, which expanded to US$11.97 billion in 2023.The region's leadership is supported by a strong biotechnology ecosystem, advanced healthcare infrastructure, and the presence of leading academic research institutions. The United States, in particular, benefits
More news about: DataM Intelligence 4 Market Research LLP
Dec 28, 2025, 20:58 ET Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates
www.harbourbiomed.com.About Yantai Lannacheng Biotechnology Co., Ltd.Founded in 2021, Lannacheng is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of integrated theranostic radiopharmaceuticals
More news about: Harbour BioMed
Dec 26, 2025, 10:50 ET Individual Quick Freezing (IQF) Market Surges to USD 9.24 Billion by 2033, Propelled by 6.2% CAGR - Verified Market Reports®
beyond food: While food processing remains the dominant application, IQF systems are increasingly used in pharmaceuticals, nutraceuticals, and biotechnology for cryopreservation of active ingredients, probiotics, and temperature-sensitive biological materials. This diversification is opening higher-margin
More news about: Verified Market Reports
Dec 26, 2025, 09:01 ET From Follower to Force: China's Biotech Sector Enters the Global Clinical Mainstream
systems confront aging populations and chronic disease, China's biotechnology sector is becoming an indispensable contributor to global innovation.About HELP TherapeuticsHelp Therapeutics is a pioneering biotechnology company dedicated to revolutionizing the treatment of degenerative
More news about: HELP Therapeutics
Dec 26, 2025, 02:29 ET Fermenta Ranked Among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
assessment of leadership and people practicesReinforces Fermenta's position as an employer of choice in the pharmaceuticals, healthcare and biotechnology sectorsTHANE, India, Dec. 26, 2025 /PRNewswire/ -- Fermenta
More news about: Fermenta Biotech Limited
Dec 25, 2025, 22:03 ET Science and Technology Daily Releases 2025 Top Sci-tech News
This discovery clarifies the totipotency mechanism in plant cells and offers new possibilities for genetic improvement of crops and agricultural biotechnology.8. China's Scientists First to Prepare Large-area Two-dimensional Metal MaterialsScientists from the Institute of Physics, Chinese
More news about: Science and Technology Daily
Dec 24, 2025, 05:11 ET Architects of Progress: Celebrating India's Most Influential Knowledge Leaders
emerging as one of India's most dynamic biotechnology and green innovation enterprises, redefining the intersection of science, sustainability, and entrepreneurship. Formerly known as JE JE Enterprises Private Limited, the organisation operates across algae biotechnology, nutraceuticals, controlled-environment
More news about: Kiteskraft Productions LLP
Dec 23, 2025, 20:20 ET Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
CAMBRIDGE, Mass., Dec. 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the expansion of its integrated discovery and
More news about: Nona Biosciences
Dec 23, 2025, 07:00 ET The TANAKA Growth Fund Achieves #1 Lipper Ranking for 5-Year Performance Through November 2025
with 12 holdings up more than 30% year-to-date and three positions more than tripling, driven by contributions from multiple sectors including biotechnology, critical minerals, clean energy, consumer staples, mining, technology, and semiconductors. We remain focused on sourcing and researching new opportunities
More news about: Tanaka Capital Management
Dec 22, 2025, 12:00 ET BioFlorida Announces Appointment of Dr. Anthony Japour, CEO of iTolerance, Inc., as Chair of the Southeast Chapter
foster connections and support continued growth in the Southeast Florida life sciences community."Anthony brings deep experience across biotechnology and large pharmaceutical organizations, along with a strong understanding of what it takes to build and scale innovation," said Mark Glickman, president
More news about: BioFlorida
Dec 22, 2025, 10:15 ET Single-molecule Real-time (SMRT) Sequencing worth $5.32 billion by 2030| MarketsandMarkets™
others.Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingRelated Reports:
More news about: MarketsandMarkets
Dec 22, 2025, 10:01 ET Next-generation Sequencing Services Market worth $8.77 billion by 2030 | MarketsandMarkets™
others.Browse Adjacent Markets: Biotechnology Market Research Reports & ConsultingRelated Reports:
More news about: MarketsandMarkets
Dec 22, 2025, 09:17 ET NeuroSense Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimer's Phase 2 Study
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today reported completion of the safety analysis from its proof-of-concept
More news about: NeuroSense
Dec 22, 2025, 08:36 ET Origin Agritech Holds Annual R&D and Operations Management Conference, Establishes 2026 Strategic Priorities
approach to R&D innovation and commercial execution positions Origin to capitalize on the significant growth opportunities in China's agricultural biotechnology sector."The Company introduced its new core values framework, creatively expressed through the ORIGIN acronym:O:
More news about: Origin Agritech Limited